Overview of Elitan
| Property | Description |
|---|---|
| Active ingredient | Metoclopramide (as hydrochloride salt) |
| Form | Tablets, Oral Solution, Solution for Injection |
| Pharmacological class | Prokinetic Agent and Antiemetic |
| Common use | Prevention and management of nausea and vomiting |
| Origin | Synthetic compound (substituted benzamide) |
Elitan is a prescription pharmaceutical preparation whose sole active ingredient is the synthetic compound Metoclopramide. It is utilized for its dual defining pharmacological properties as a prokinetic agent and a potent antiemetic. As a single-ingredient product, Elitan's therapeutic action relies exclusively on this one chemical entity, a substituted benzamide. For clinical necessity, it is available in several dosage form(s), including oral tablets and a sterile solution for injection for parenteral administration.
What Type of Medicine is Elitan? (Classification and Origin)
Elitan is primarily classified as an antiemetic, meaning its fundamental role is to relieve or prevent nausea and vomiting. This function is achieved due to its action as a dopamine D2 receptor antagonist. Pharmacological studies have consistently supported this mechanism, confirming its efficacy in blocking the chemical signals in the brain that trigger the vomiting reflex. The drug's synthetic origin places it within the established category of modern, chemically defined pharmaceuticals.
Uniquely, Metoclopramide simultaneously acts as a powerful prokinetic agent through stimulating the upper digestive tract. This dual action differentiates it from medications that only target the central nervous system. A neutral use scenario involves managing nausea associated with conditions where slow stomach emptying is a factor.
Elitan's Form and General Therapeutic Purpose
The provision of Elitan in multiple forms, from the stable tablets to the rapidly absorbed solution for injection, ensures flexibility in the route of administration depending on the severity of the patient's condition. The dual pharmacological classification directly connects to the drug’s general therapeutic purpose: to manage and prevent episodes of severe nausea and vomiting. This goal is achieved by simultaneously suppressing the central sickness signal and promoting the forward movement of stomach contents, thus addressing two common physiological factors contributing to sickness.
Regulatory References
